Delivery Order SPE2DB22D2206-SPE2DB24FHX55

Award Date 6/25/24
Potential Completion Date 7/17/24
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Venclexta 100 mg tablets, a prescription medication. The contract has a ceiling value of $9,728.17 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $8,880.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Venclexta 100 mg tablets. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 2, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Venclexta 100 mg tablets. The contract has a ceiling value of $9,728.17 and a period of performance through July 17, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,826.42 and is for the delivery of Venclexta 100 mg tablets. It is a firm-fixed-price contract with a completion date of June 13, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corporation holds a significant...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $9,728.17, is for the delivery of Venclexta 100 mg tablets. This is a firm fixed-price delivery order contract with a performance period through May 2, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
The federal contract award is for the delivery of Venclexta 100 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $19,456.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a firm fixed price delivery order for the medication Venclexta (Venetoclax) 100 mg tablets. The award has a ceiling value of $8,880.15 and a period of performance through April 19, 2024. This delivery order is placed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA, which has a potential value...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug Venclexta 100 mg tablets. The contract is a delivery order with a firm fixed price of $8,880.15 and a completion date of May 16, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Venclexta 100 mg tablets. The contract has a ceiling value of $4,443.68 and is a firm fixed-price arrangement. The ultimate completion date is November 5, 2024. This award is not associated with any set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for...
This federal contract award is for the delivery of Venclexta 100mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract has a ceiling value of $8,880.15 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 21, 2024. The contract is not set aside and was awarded under the DLA's Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHX55
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Venclexta 100 mg tablets, a prescription medication, to the government. The contract has a ceiling value of $26,640.45 and a completion date of July 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. The contract does not have a set-aside designation.

Generated 9/24/24, 9:32 AM